Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
38375
CAS Number:
81938-43-4
Zofenopril cálcico
Purity:
≥ 97 % (HPLC)
Synonym(s):
(4S)-1-[(2S)-3-(benzoiltio)-2-metil-1-oxopropil]-4-(feniltio)-L-prolina, sal de calcio
Documents
$334.10 /25 mg
Tamaño
Request Bulk Quote
Información del producto

Zofenopril calcium is a potent angiotensin-converting enzyme (ACE) inhibitor, primarily utilized in the management of hypertension and heart failure. This compound is recognized for its ability to effectively lower blood pressure and improve cardiac function, making it a valuable asset in cardiovascular therapy. Its unique structure allows for enhanced bioavailability and prolonged action compared to other ACE inhibitors, providing patients with sustained therapeutic benefits.

In addition to its primary applications in treating cardiovascular conditions, Zofenopril calcium has shown promise in research settings, particularly in studies focused on renal protection and diabetic complications. Its ability to mitigate oxidative stress and inflammation further underscores its potential in various therapeutic areas. Researchers and healthcare professionals can leverage Zofenopril calcium's multifaceted benefits to improve patient outcomes in both clinical and experimental settings.

Número CAS
81938-43-4
Fórmula molecular
C44H44CaN2O8S4
Peso molecular
897.16
Número MDL
MFCD11858294
Punto de fusión
246 °C
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
81938-43-4
Fórmula molecular
C44H44CaN2O8S4
Peso molecular
897.16
Número MDL
MFCD11858294
Punto de fusión
246 °C
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Zofenopril calcium is widely utilized in research focused on:

  • Cardiovascular Health: This compound is primarily used in the treatment of hypertension and heart failure, helping to manage blood pressure effectively and reduce the risk of cardiovascular events.
  • Pharmaceutical Development: Zofenopril calcium serves as a key ingredient in various antihypertensive medications, making it crucial for pharmaceutical companies developing new treatments for high blood pressure.
  • Clinical Research: Researchers often study its effects in clinical trials to better understand its efficacy and safety profile compared to other ACE inhibitors, providing valuable data for healthcare professionals.
  • Combination Therapies: It is frequently used in combination with other antihypertensive agents, enhancing treatment outcomes for patients with complex health conditions.
  • Patient Compliance: The formulation of Zofenopril calcium allows for once-daily dosing, which can improve patient adherence to treatment regimens, a significant advantage in chronic disease management.

Citas